Cargando…

Intramuscular lesions in musculoskeletal MRI as a favourable prognostic sign in patients with anti-MDA5 antibody-positive dermatomyositis

OBJECTIVES: Anti-differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis, which has been described as clinically amyopathic dermatomyositis, complicates rapidly progressive interstitial lung disease (ILD). Owing to the absence of significant muscle symptoms, musculoskeletal MRI is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oto, Yohsuke, Yoshida, Ken, Fukuda, Takeshi, Fukuda, Taiki, Ukichi, Taro, Noda, Kentaro, Ito, Haruyasu, Kurosaka, Daitaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Myositis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462980/ https://www.ncbi.nlm.nih.gov/pubmed/37640514 http://dx.doi.org/10.1136/rmdopen-2023-003271

Ejemplares similares

Angiogenesis and VEGF-expressing cells are identified predominantly in the fascia rather than in the muscle during the early phase of dermatomyositis
por: Yoshida, Ken, et al.
Publicado: (2017)

Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab
por: Ostendorf, Lennard, et al.
Publicado: (2023)

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I
por: Zhang, Lu, et al.
Publicado: (2023)

Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease
por: Chen, Xixia, et al.
Publicado: (2023)

Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis
por: Wilkinson, Meredyth G Ll, et al.
Publicado: (2023)

Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments
por: Kawahata, Kimito, et al.
Publicado: (2023)

MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis
por: Ukichi, Taro, et al.
Publicado: (2019)

Aberrant Muscle Antigen Exposure in Mice Is Sufficient to Cause Myositis in a Treg Cell–Deficient Milieu
por: Young, Nicholas A, et al.
Publicado: (2013)

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups
por: Rothwell, Simon, et al.
Publicado: (2019)

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis
por: Lilleker, James B, et al.
Publicado: (2019)

Immune‐Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA–DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum
por: Rothwell, Simon, et al.
Publicado: (2017)

Muscle Weakness in Myositis: MicroRNA‐Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies
por: Kinder, Travis B., et al.
Publicado: (2020)

Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies
por: Che, Weng Ian, et al.
Publicado: (2021)

Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies
por: Zhou, Danlei, et al.
Publicado: (2023)

Severe case of rhabdomyolysis following jellyfish envenomation in the Mediterranean Sea
por: Buscetta, Giorgio, et al.
Publicado: (2023)

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case–control study
por: Pijnenburg, Luc, et al.
Publicado: (2023)

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Prokineticin 2 antagonist, PKRA7 suppresses arthritis in mice with collagen-induced arthritis
por: Ito, Haruyasu, et al.
Publicado: (2016)

Fasciitis as a disease manifestation in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies: a case report of two cases
por: Yoshida, Ken, et al.
Publicado: (2018)

Generalized severe myalgia and oedema: a case of fasciitis associated with mixed connective tissue disease
por: Noda, Kentaro, et al.
Publicado: (2022)

Clinical Images: Unilateral Jaccoud's arthropathy in a patient with relapsing polychondritis
por: Oto, Yohsuke, et al.
Publicado: (2022)

Autocitrullination confers monocyte chemotactic properties to peptidylarginine deiminase 4
por: Yoshida, Ken, et al.
Publicado: (2023)

Elevation of Bombina variegata peptide 8 in mice with collagen-induced arthritis
por: Kurosaka, Daitaro, et al.
Publicado: (2009)

Alterations of voluntary behavior in the course of disease progress and pharmacotherapy in mice with collagen-induced arthritis
por: Oto, Yohsuke, et al.
Publicado: (2019)

Sustained microglial activation in the area postrema of collagen-induced arthritis mice
por: Matsushita, Takayuki, et al.
Publicado: (2021)

Spontaneous Intramuscular Hemorrhage in Anti-MDA5 Positive Dermatomyositis: A Case Series and Literature Review
por: Xu, Zhangling, et al.
Publicado: (2022)

7. Anti-MDA5 associated dermatomyositis
por: Laverty, Ursula, et al.
Publicado: (2019)

Editorial: Anti-MDA5-Positive Dermatomyositis
por: Gono, Takahisa, et al.
Publicado: (2022)

Olfactory Bulbs in Arthritis Model Mouse Persistently Express Interleukin-6 before the Onset of Arthritis: Relationship to Food Intake
por: Otani, Kazuhiro, et al.
Publicado: (2023)

Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositis
por: Kotsiou, Ourania S., et al.
Publicado: (2017)

Therapiealternativen bei amyopathischer MDA5-positiver Dermatomyositis
por: Schumacher, Falk, et al.
Publicado: (2023)

Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis
por: Sakamoto, Noriho, et al.
Publicado: (2018)

On the Nose: Anti-MDA-5 Dermatomyositis Manifesting as Perinasal Swelling
por: Molina, Emily, et al.
Publicado: (2022)

Fibrocellular non‐specific interstitial pneumonia with favourable prognosis in clinically amyopathic dermatomyositis
por: Yoshizawa, Takahiro, et al.
Publicado: (2016)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023)

Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib
por: Luo, Man, et al.
Publicado: (2022)

Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
por: Bobirca, Anca, et al.
Publicado: (2022)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Subcutaneous Calcinosis in a Patient with Anti-MDA5 Positive Dermatomyositis
por: Hou, Ruihong, et al.
Publicado: (2021)

The “Tail Sign” in Intramuscular Schwannoma
por: Khamlichi, Hamza, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m0mtorfma3dn2s59tvojajg8g9